Our Company

Objectivity matters. Today, more than ever.

Independent for over 60 years, Milliman delivers market-leading services and solutions to clients worldwide. With no agenda, other than getting it right.

Through a team of professionals ranging from actuaries to clinicians, technology specialists to plan administrators, we offer unparalleled expertise in employee benefits, investment consulting, healthcare, life insurance and financial services, and property and casualty insurance.

News

See all news

Solutions

STAR Solutions - NAVI

Reduce risk calculation time and gain insight into risk exposure.

CORAL: A roadmap for ACA

CORAL helps you quickly estimate relative values of health benefit plans.

InvestMap

A sophisticated tool that enables DC plan sponsors to deploy an age-based, asset-allocation strategy.

Site of Service Cost Differences for Medicare Patients Receiving Chemotherapy

  • Print
  • PDF
  • Connect
  • Email
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
Bruce S. Pyenson, Kathryn V. Fitch | 19 October 2011

Cancer is an important cost issue for Medicare. About eight million of the almost 14 million Americans living with cancer are over age 65, and approximately half of cancer care spending is associated with Medicare beneficiaries.

This paper examines differences in the cost of care for Medicare fee for service cancer patients depending on the site of chemotherapy service: a physician’s office or a hospital outpatient setting. The analysis is based on the Medicare Limited Data Set (LDS) for 2006-2009.

This paper was commissioned by McKesson Specialty Health, a division of McKesson Corporation, on behalf of The US Oncology Network.